294 related articles for article (PubMed ID: 35496321)
21. Identification and validation of a novel nine-gene prognostic signature of stem cell characteristic in hepatocellular carcinoma.
An Y; Liu W; Yang Y; Chu Z; Sun J
J Appl Genet; 2024 Mar; ():. PubMed ID: 38441798
[TBL] [Abstract][Full Text] [Related]
22. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients.
Wang Z; Zhang N; Lv J; Ma C; Gu J; Du Y; Qiu Y; Zhang Z; Li M; Jiang Y; Zhao J; Du H; Zhang Z; Lu W; Zhang Y
Biomed Res Int; 2020; 2020():4037639. PubMed ID: 33163533
[TBL] [Abstract][Full Text] [Related]
23. A New Prognostic Strategy Based on four DNA Repair-Associated lncRNAs for Hepatocellular Carcinoma.
Zeng H; Liu C; Zhou X; Liu L
Comb Chem High Throughput Screen; 2022; 25(5):906-918. PubMed ID: 33653241
[TBL] [Abstract][Full Text] [Related]
24. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
[TBL] [Abstract][Full Text] [Related]
25. A stemness-based eleven-gene signature correlates with the clinical outcome of hepatocellular carcinoma.
Hong L; Zhou Y; Xie X; Wu W; Shi C; Lin H; Shi Z
BMC Cancer; 2021 Jun; 21(1):716. PubMed ID: 34147074
[TBL] [Abstract][Full Text] [Related]
26. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Yan Z; He M; He L; Wei L; Zhang Y
Front Immunol; 2021; 12():723271. PubMed ID: 34925311
[TBL] [Abstract][Full Text] [Related]
27. A metabolism-related gene signature for predicting the prognosis and therapeutic responses in patients with hepatocellular carcinoma.
Dai X; Jiang W; Ma L; Sun J; Yan X; Qian J; Wang Y; Shi Y; Ni S; Yao N
Ann Transl Med; 2021 Mar; 9(6):500. PubMed ID: 33850897
[TBL] [Abstract][Full Text] [Related]
28. Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
Ni W; Bian S; Zhu M; Song Q; Zhang J; Xiao M; Zheng W
Front Oncol; 2021; 11():629327. PubMed ID: 33718205
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma.
Chen S; Zhao E
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631
[TBL] [Abstract][Full Text] [Related]
30. A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma.
Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Shi N; Jin H
J Clin Lab Anal; 2021 Nov; 35(11):e24005. PubMed ID: 34523732
[TBL] [Abstract][Full Text] [Related]
31. Identification and Validation of a Novel DNA Damage and DNA Repair Related Genes Based Signature for Colon Cancer Prognosis.
Wang XQ; Xu SW; Wang W; Piao SZ; Mao XL; Zhou XB; Wang Y; Wu WD; Ye LP; Li SW
Front Genet; 2021; 12():635863. PubMed ID: 33719345
[No Abstract] [Full Text] [Related]
32. Construction of a lipid metabolism-related and immune-associated prognostic score for gastric cancer.
Dai J; Li Q; Quan J; Webb G; Liu J; Gao K
BMC Med Genomics; 2023 May; 16(1):93. PubMed ID: 37138287
[TBL] [Abstract][Full Text] [Related]
33. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
Li W; Lu J; Ma Z; Zhao J; Liu J
Front Genet; 2019; 10():1323. PubMed ID: 32010188
[No Abstract] [Full Text] [Related]
34. Identification of a Liver Progenitor Cell-Related Genes Signature Predicting Overall Survival for Hepatocellular Carcinoma.
Li X; Lin J; Pan Y; Cui P; Xia J
Technol Cancer Res Treat; 2021; 20():15330338211041425. PubMed ID: 34866477
[No Abstract] [Full Text] [Related]
35. Stemness analysis in hepatocellular carcinoma identifies an extracellular matrix gene-related signature associated with prognosis and therapy response.
Chen L; Zhang D; Zheng S; Li X; Gao P
Front Genet; 2022; 13():959834. PubMed ID: 36110210
[No Abstract] [Full Text] [Related]
36. Identification and validation in a novel quantification system of the glutamine metabolism patterns for the prediction of prognosis and therapy response in hepatocellular carcinoma.
Jin S; Cao J; Kong LB
J Gastrointest Oncol; 2022 Oct; 13(5):2505-2521. PubMed ID: 36388696
[TBL] [Abstract][Full Text] [Related]
37. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
38. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
Fu XW; Song CQ
Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
[No Abstract] [Full Text] [Related]
39. Characterization of DNA Damage Repair Related Signature and Molecular Feature in Low-Grade Gliomas to Aid Chemotherapy and Drug Discovery.
Yin X; Li M; He Z
Front Biosci (Landmark Ed); 2023 Oct; 28(10):234. PubMed ID: 37919061
[TBL] [Abstract][Full Text] [Related]
40. Development and validation of epithelial mesenchymal transition-related prognostic model for hepatocellular carcinoma.
Wang X; Xing Z; Xu H; Yang H; Xing T
Aging (Albany NY); 2021 Apr; 13(10):13822-13845. PubMed ID: 33929972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]